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Summary statement: EHRA
Summit 2010 with the
Participation of Central-
Eastern European Countries:
‘ICD for Life’ Initiative—
Fighting against Sudden
Cardiac Death in Emerging
Economies
The conference of the ‘Implantable Cardiover-
ter Deﬁbrillator for Life’ Initiative—Fighting
against Sudden Cardiac Death in Emerging
Economies was jointly organized by the Euro-
pean Heart Rhythm Association and the Hun-
garian Society of Cardiology.
The aim of the summit was to demonstrate
the beneﬁt and efﬁcacy of the prevention of
sudden cardiac death (SCD). Sudden cardiac
death is responsible for a signiﬁcant number
of deaths at an annual level and it is the
leading cause of death in industrial countries.
Many arrhythmias could be treated by means
of device therapy and this would also reduce
the death rates. The target of the summit was
to build bridges between medical, political,
andindustrialsectorstoprocuregreaterpoliti-
cal and economic care and support for the
primary and secondary prevention of sudden
cardiac death, heart failure, and arrhythmias.
The number of implantable cardioverter-
deﬁbrillator (ICD) implantations has increased
enormously in the recent years based on the
proven efﬁcacy of implantable devices in the
treatment of heart failure and heart rhythm dis-
turbances. However, many patients with high
risk of SCD still do not undergo ICD implan-
tation. The reason is partly economic, and
partly due to the lack of public awareness and
the lack of qualiﬁed specialists. The conference
emphasized that both the theoretical back-
ground of device therapy—professional rec-
ommendations, choice of implantable devices,
programming, and problem solving—and the
practical education of implantation methods
are important to increase the implantation
rates. The paradoxity of the effort to reduce
SCD in economies in transition is that there is
a high prevalence of high-risk patients on one
side and actual implant rates both for primary
and secondary prevention are disproportially
low.
The summit attempted to reﬂect regional
disparities, their political, economic, ﬁnancial,
and, last but not least, educational background
through a series of lectures held by the repre-
sentatives of countries with low, medium, and,
high implantation rates. The importance of
patient organizations was also emphasised;
they may play a crucial role in the improve-
ment of patients’ quality of life, in risk
reduction, and in prevention of SCD in the
European population. At the end of the ses-
sions, Central-Eastern European cardiologists,
health-economists, politicians, and journalists
discussed the reasons for and the possible
solutions to the regional differences within
the roundtable discussions. Acknowledging
the importance, the timeliness and the
message of the topic, Pa ´l Schmitt, President
of the Hungarian Republic, and Miklo ´sR e ´the-
lyi, Minister of National Resources, undertook
the main patronage of the event.
Invitation letters were sent to the presi-
dents of all Cardiology Societies and Arrhyth-
mia Working Groups in the member states of
ESC as well as to all decision-makers of EHRA
(Board Members and Committee Members).
Finally, 197 registered participants from 31
countries arrived.
TheprogrammeoftheSummitwasarranged
onthebasisoftheparticipants’feedback;alsoa
teleconference with the leadership of EHRA
was organized to discuss the key points
programme. The Faculty was composed of
55 renowned cardiologist-arrhythmologists,
health-economical, and political experts who
represented 27 countries (Armenia, Belarus,
Belgium, Croatia, Czech Republic, Estonia,
F.Y.R.O. Macedonia, Georgia, Germany,
Greece, Hungary, Israel, Italy, Latvia, Lebanon,
Lithuania, Montenegro, Poland, Romania,
Russia, Serbia, Slovakia, Slovenia, Switzerland,
Turkey, UK, and Ukraine) and acted as invited
chairs, and speakers in different sessions.
The event was preceded by a press confer-
ence with Prof. Panos Vardas, Prof. Be ´la
Merkely, Prof. Christian Wolpert, Prof.
Goran Milasinovic, and Prof. Pe ´ter Jo ´zan.
Based on the number of participants, media
journalists, and media appearances, the press
conference can be considered extremely
successful.
Prof. Panos Vardas, the president of EHRA
and the president-elect of the ESC, Prof. Be ´la
Merkely, the President of the Hungarian
Society of Cardiology and the Co-chairman of
the National Societies Board of EHRA, and
Ms Ma ´ria Se ´lleine ´ Ma ´rki, the Director
General of the National Health Insurance
Fund of Hungary, opened the ﬁrst session of
the event. Subsequently, speakers focused on
the health care and health economical differ-
ences among the European member states. In
his talk, Prof. Pe ´ter Jo ´zan discussed the cardio-
vascular epidemiological differences. Dr Pe ´ter
Gaa ´l explained the health economical difﬁcul-
ties of the treatment of SCD. Prof. Stefan
Ka ¨a ¨b held a lecture on the epidemiology of
SCD and then Prof. Miran Kenda summarized
the relationship between diabetes and SCD.
Intheclosingtalkofthesession,Prof.Christian
Wolpert reviewed the concept, the birth, and
the development of the EHRA White Book,
the annual publication of the Association
representing current status of cardiac electro-
physiology of the member states.
The second session was dedicated to the
evidence on device therapy to ﬁght SCD,
both in primary and secondary preventions.
The reviews by Dr Zolta ´n Csana ´di, Prof.
Robert Hatala, and Prof. Andrzej Lubinski
covered the existing guidelines on ICD
implants. Prof. Milos Taborsky presented
data obtained during the previous EHRA—
Eastern Initiative Meeting held in February
2010 in Pilsen. His lecture was followed by a
roundtable discussion.
In the third session on cardiac resynchroni-
zation therapy, Prof. Be ´la Merkely summar-
ized the latest evidence on efﬁcacy of the
treatment. On behalf of the National Health
Insurance Fund of Hungary, Dr Jo ´zsef Gajda ´csi
explained the health economical background,
and the ﬁnancial model of this special, expens-
ive, but cost-effective treatment. He pre-
sented the algorithms for decision making in
Hungary.
In the fourth session, Prof. Frans Van de
Werf focused on the process of establish-
ment and implementation of international
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Camm and Michael Glikson followed empha-
sizing the costs of ICD treatment and explain-
ing how the expenditure of the treatment
inﬂuences the number of patients actually
receiving it. As implant rates of implantable
devices depend also on the critical mass of
available specialists in each country, Prof.
Josef Kautzner focused on the need for edu-
cation and outlined the policy of EHRA
regarding the Central-Eastern European edu-
cation in arrhythmology.
In the next session, Prof. Davor Milicic and
George Andrei Dan discussed complex ques-
tions such as the treatment of SCD as a screen
of patients with high-risk factors, the establish-
ment of proper predictive factors and their
possible applications in clinical practice. Prof.
Alessandro Proclemer introduced a separate
lecture on the Italian Pacemaker/ICD registry.
Follow-up data in this registry were considered
very important. Prof. Amiran Revishvili closed
the sessionwithatalkon ablationofventricular
tachycardias and its importance in management
of ICD patients with recurrent and frequent
ventricular arrhythmias.
The lectures in the last session dealt with
the management of patients with an ICD
device and with the role of patient organiz-
ations in patient care. Dr Roland Dieckmann,
Ms Pavla Kristofova, and Ms Trudie Lobban
presented the system and the achievements
of the German, Czech, and British models.
Ms Trudie Lobban highlighted that the
British Arrhythmia Alliance-developed guide-
lines and supported establishing a patient-
focused arrhythmia organization, working in
partnership with clinicians. The organization
offers website templates and other materials
that can be translated into the local language
and they offer additional help to establish
local alliances. Besides, they can then help
identify and train an administrator in the
country to move the organizations forward
and raise awareness. More information can be
found at: www.heartrhythmcharity.org.uk/
international-area. A new international site
was also launched in March 2011: www.afa-
international.org and www.stars-international.
org.
Finally, history, goals, and the planned
future of the Eastern Initiative within the
EHRA were summarized by Prof. Goran Mila-
sinovic. Prof. Karl-Heinz Kuck projected the
future perspectives of the treatment of SCD
in Eastern Europe.
The participants had the opportunity to
introduce the practice and data of their own
countries, and to reﬂect on their political-
economicbackgroundinseveralroundtabledis-
cussions. All the roundtable discussions were
followed by presentation of a vision of the
futureandthepolicyofthegiventreatment,pre-
viously discussed in the section.
As the site of the latest EHRA Summit,
Hungary had been chosen by the European
Society of Cardiology as one of the countries
where the number of implanted cardiac
rhythm management devices approaches the
healthcare demands. Hungary is part of the
‘green region’ of Eastern Europe where the
number of implanted devices grows at an ade-
quate rate and there is an existing infrastruc-
ture for this therapy. As organizing the
summit, the Hungarian Society of Cardiology
could introduce its decennial work, an
exemplary in the region.
The main message of the EHRA Summit
was that the professional collaboration does
not sufﬁce to remain within the country
borders for the prevention of SCD. The col-
laboration has to cross borders to develop
uniﬁed international professional, health
economical, and health political strategy.
Therefore,thesummitreachedtheconsensus
of creating a working board called ‘Working
Board of Eastern Initiative’ (WBEA) within the
EHRA,to delegateindividual personsforspeciﬁc
tasks.AsProf.ChristianWolpertandProf.Panos
Vardas supported the idea, the WBEA was
formed at the end of the summit. The
members of the WBEA are Profs. Christian
Wolpert, Be ´la Merkely, Josef Kautzner, Goran
Milasinovic, Robert Hatala, George Andrei Dan,
Milos Taborsky, and Zolta ´nC s a n a ´di.
The tasks of this working board are the fol-
lowing: ﬁrst, based on personal communication
with the cardiologist and arrhythmologist
leaders of the speciﬁc region, Goran Milasino-
vic will deﬁne and analyse the speciﬁc regional
problems and obstacles in each country. The
analysis will detail the problems to be solved
as to improve the efﬁcacy of the prevention
of SCD (e.g. lack of well-trained experts and
sufﬁcient knowledge, lack of referrals, infra-
structural background, and reimbursement).
The report will be sent to WBEA to set the
targets for the next 3 years to solve the
most urgent problems in each country. Sec-
ondly, WBEA will suggest speciﬁc education
policy and establish a list of training centres
in the Eastern-European countries. Prof. Josef
Kautzner will be responsible for creating an
educational plan for all regions and for deﬁning
the rules and minimal requirements that have
to be fulﬁlled by the Eastern European training
centres. Thirdly, to increase awareness of SCD
among professionals and in public, EHRA will
help to organize lectures at national cardiology
and arrhythmology meetings in the region and
promote the foundation of patient organiz-
ations. Fourthly, together with the EHRA
Board they will ﬁnd the way to support the
above educational activities in Eastern Europe.
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Angelo Auricchio (Switzerland)
Imre Benedek (Romania)
Tatsiana Burmistrava (Belarus)
John Camm (UK)
Zolta ´n Csana ´di (Hungary)
George Andrei Dan (Romania)
Alexandru Deutsch (Romania)
Roland Dieckmann (Germany)
Dan Dobreanu (Romania)
Kakhaber Etsadashvili (Georgia)
Pe ´ter Gaa ´l (Hungary)
Jo ´zsef Gajda ´csi (Hungary)
Nikola Gjorgov (F.Y.R.O. Macedonia)
Michael Glikson (Israel)
Robert Hatala (Slovakia)
Ashot Hovhannesyan (Armenia)
Charles Jazra (Lebanon)
Pe ´ter Jo ´zan (Hungary)
Stefan Ka ¨a ¨b (Germany)
Oskars Kalejs (Latvia)
Josef Kautzner (Czech Republic)
Miran Kenda (Slovenia)
Pavla Kristofova (Czech Republic)
Karl-Heinz Kuck (Germany)
Andrzej Kutarski (Poland)
Trudie Lobban (UK)
Andrzej Lubinski (Poland)
Germanas Marinskis (Lithuania)
Be ´la Merkely (Hungary)
Goran Milasinovic (Serbia)
Davor Milicic (Croatia)
Przemyslaw Mitkowski (Poland)
Ljilja Music (Montenegro)
Ali Oto (Turkey)
Yulia Persidskikh (Belarus)
Alessandro Proclemer (Italy)
Amiran Revishvili (Russia)
Ma ´ria Se ´lleine ´ Ma ´rki (Hungary)
Milos Taborsky (Czech Republic)
Panos Vardas (Greece)
Radu Vatasescu (Romania)
Ju ¨ri Voitk (Estonia)
Dmitrij Volkov (Ukraine)
Frans Van de Werf (Belgium)
Christian Wolpert (Germany)
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